首页|期刊导航|山西大学学报(自然科学版)|川芎嗪缓解顺铂神经毒性的作用及机制研究

川芎嗪缓解顺铂神经毒性的作用及机制研究OA

The Effect and Underlying Mechanism of Ligustrazine on Relieving Cisplatin-induced Neurotoxicity

中文摘要英文摘要

顺铂临床应用常伴剂量依赖性周围神经毒性,缺乏理想防护药物,而川芎嗪具备显著神经保护活性,本研究探讨川芎嗪预防顺铂诱导神经毒性的潜在作用机制.采用网络药理学方法,通过SwissTarget Prediction和比较毒理基因组学数据库(Comparative Toxicogenomics Database,CTD)获取川芎嗪靶点,经GeneCards、CTD和人类孟德尔遗传数据库(Online Mendelian Inheritance in Man,OMIM)筛选顺铂及神经毒性相关靶点;利用蛋白质互作检索工具数据库(Search Tool for the Retrieval of Interacting Genes/Proteins,STRING)进行蛋白质相互作用(Protein-protein interaction,PPI)分析并筛选关键靶点;通过Hiplot系统进行基因本体(Gene Ontology,GO)与京都基因与基因组百科全书(Kyoto Enycyclopedia of Genes and Genomes,KEGG)富集分析;采用分子对接及体外实验,包括细胞计数试剂盒8检测法(Cell Counting Kit-8,CCK-8)、实时荧光定量聚合酶链式反应(Real-time Quantitative Poly-merase Chain Reaction,RT-qPCR)和酶联免疫吸附试验(Enzyme-Linked Immunosorbent Assay,ELISA)进行验证.结果显示,共获得川芎嗪靶点93个,顺铂靶点11 123个,神经毒性靶点23 673个,交集靶点84个.富集分析显示,这些靶点参与3 698个生物过程、361个分子功能、236个细胞组分及234条信号通路.分子对接表明川芎嗪与白细胞介素6(Interleukin-6,IL-6)、肿瘤坏死因子(Tumor Necrosis Factor,TNF)、缺氧诱导因子1A(Hypoxia-Inducible Factor 1 Alpha,HIF1A)的结合能均低于-4 kcal/mol.体外实验证实,川芎嗪可显著提高顺铂损伤的神经细胞存活率(P<0.05),并下调TNF、IL-6、HIF1A的mRNA和蛋白表达水平(P<0.05).川芎嗪可能通过抑制IL-6、TNF、HIF1A等核心靶点,调控IL-17、HIF1A及TNF信号通路,减轻炎症与氧化应激反应,发挥改善顺铂诱导神经毒性的作用.

Cisplatin is frequently accompanied by dose-dependent peripheral neurotoxicity in clinical practice,and there is a lack of ideal protective agents.Ligustrazine possesses prominent neuroprotective activity.In this paper,network pharmacology was em-ployed to investigate the potential mechanism by which ligustrazine prevents cisplatin-induced neurotoxicity.Ligustrazine targets were obtained from the SwissTarget Prediction and Comparative Toxicogenomics Database(CTD).Targets associated with cisplatin and neurotoxicity were screened using the GeneCards,CTD,and Online Mendelian Inheritance in Man Databases(OMIM).Protein-protein interaction(PPI)analysis was conducted via the STRING database to identify key targets.Gene Ontology(GO)and Kyoto Enycyclopedia of Genes and Genomes(KEGG)enrichment analyses were performed using the Hiplot platform.Validation was car-ried out through molecular docking and in vitro experiments,including Cell Counting Kit-8 assay(CCK-8),Real-time Quantitative Polymerase Chain Reaction(RT-qPCR),and Enzyme-Linked Immunosorbent Assay(ELISA).The results show that a total of 93 li-gustrazine targets,11 123 cisplatin-related targets,and 23 673 neurotoxicity-related targets were retrieved,with 84 overlapping tar-gets.Enrichment analysis revealed that these targets were involved in 3 698 biological processes,361 molecular functions,236 cellu-lar components,and 234 signaling pathways.Molecular docking demonstrated that ligustrazine exhibited binding energies below-4 kcal/mol with Interleukin-6(IL-6),Tumor Necrosis Factor(TNF),and Hypoxia-Inducible Factor 1 Alpha(HIF1A).In vitro ex-periments confirmed that ligustrazine significantly increased the viability of cisplatin-damaged neuronal cells(P<0.05)and down-regulated both mRNA and protein expression levels of TNF,IL-6,and HIF1A(P<0.05).Ligustrazine likely exerts therapeutic ef-fects against cisplatin-induced neurotoxicity by inhibiting core targets such as IL-6,TNF,and HIF1A,modulating IL-17,HIF1A,and TNF signaling pathways,and thereby alleviating inflammatory and oxidative stress responses.

冯春琪;刘玉强;康杰;赵永泽;秦智超;王皎;陈维红;李杏花

长治市人民医院 药学部,山西,长治 046000||山西医科大学 药学院,山西 太原 030600长治市人民医院 药学部,山西,长治 046000山西医科大学 药学院,山西 太原 030600山西医科大学 药学院,山西 太原 030600长治医学院 第一临床学院,山西 长治 046000长治市人民医院 药学部,山西,长治 046000山西医科大学 药学院,山西 太原 030600长治市人民医院 药学部,山西,长治 046000||山西医科大学 上消化道肿瘤防治研究所,山西 长治 046000

医药卫生

网络药理学分子对接实验验证川芎嗪顺铂神经毒性

network pharmacologymolecular dockingexperimental verificationligustrazinecisplatinneurotoxicity

《山西大学学报(自然科学版)》 2026 (4)

592-606,15

长治市基础研究计划(自由探索类)项目(JC202431)国家卫生健康委医院管理研究所医院药学高质量发展研究项目(NIHAYS2443)

10.13451/j.sxu.ns.2026006

评论